• TheAdvanced Research Projects Agency for Health(ARPA-H) has announced the first recipients of its Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program. • The selected research teams fromCarnegie Mellon University,Wake Forest University,the Wyss Institute,University of California San Diego, andUniversity of Texas Southwestern Medical Centerwill develop advanced bioprinted organs, including livers and kidneys, designed to function without immunosuppressive drugs by using patient-specific cells or those from biobanks. • The initiative aims to produce human-sized, fully functional organs within hours, addressing the urgent shortage of transplantable organs in the United States, where thousands of patients die annually while waiting. • “Developing universally matched organs has never been done before in the history of transplantation. • Printing a precisely matched, functional human organ will fundamentally change what is possible in transplant medicine and will save countless lives,” said Alicia Jackson, Ph.D., ARPA-H Director. • “Through the PRINT program, ARPA-H will strengthen U.S.
Article Summaries:
- The Advanced Research Projects Agency for Health (ARPA-H) has announced the first recipients of its Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program. The selected research teams from Carnegie Mellon University, Wake Forest University, the Wyss Institute, University of California San Diego, and University of Texas Southwestern Medical Center will develop advanced bioprinted organs, including livers and kidneys, designed to function without immunosuppressive drugs by using patient-specific cells or those from biobanks. The initiative aims to produce human-sized, fu
Sources: